Drug details
RiaSTAP (fibrinogen concentrate (human) for intravenous use)
type of Antifibrinolytic Agents
RiaSTAP (fibrinogen concentrate human for intravenous use) is a man-made form of the protein albumin and is used to treat bleeding episodes in people who have a congenital fibrinogen deficiency. RiaSTAP is available in generic form.
This drug may have the following side effects:
- fever
- chills
- vomiting
- nausea, or
The following drugs are related to RiaSTAP, either as a replacement or used together:
- Fibryga (fibrinogen (human)] lyophilized powder for reconstitution)